| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Lyell Immunopharma, Inc. (LYEL) have been net sellers, shedding 14,188 shares worth roughly $215K on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
The insider who sold still holds shares after the sale. LYEL sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.77M | - | - | |
| 10% | 1.43M | $36.53M | - | |
| 10% | 1.43M | $36.53M | - | |
| CEO | 63.9K | $993.0K | - | |
| Other | 20.4K | $259.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | Newton Charles W.66 | Chief Financial Officer | Buy | 200,000 | $0.56 | $111,620.00 | New | -1.7% | +94.7% | |
| Mar 14, 2025 | Seely Lynn74 | President and CEO | Buy | 175,000 | $0.61 | $106,190.00 | +32.6% | -16.8% | +81.5% | |
| Mar 14, 2025 | Klausner Richard73 | Director | Buy | 158,000 | $0.60 | $94,942.20 | +23.1% | -16.8% | +81.5% | |
| Aug 15, 2023 | Klausner Richard73 | Director | Sell | 58,020 | $2.28 | $132,285.60 | -5.9% | -32.3% | -47.6% | |
| Sep 23, 2022 | Klausner Richard73 | Director | Sell | 11,100 | $6.40 | $71,041.11 | -1.1% | -52.4% | -77.1% | |
| Jun 21, 2021 | Friedman Cathy | Director | Buy | 17,648 | $17.00 | $300,016.00 | New | -33.8% | -65.7% |